NEW YORK, Feb. 6, 2020 /PRNewswire/ -- Genpact Limited G, a global professional services firm focused on delivering digital transformation, today announced financial results for the fourth quarter and full year ended December 31, 2019.
"Outstanding execution and continued Transformation Services wins capped off one of our best revenue growth years ever. This translated into healthy adjusted diluted EPS and operating cash flow growth for 2019. These metrics were all above the high end of our expectations," said "Tiger" Tyagarajan, Genpact's president and CEO. "Clients' desire for transformational change is accelerating, expanding our addressable market and providing greater opportunities for us to drive profitable long-term growth. We continue to improve the rigor and agility of our portfolio evaluation process, allowing us to quickly reallocate investment and talent resources to best penetrate high growth areas."
Key Financial Results – Full Year 2019
- Total revenue was $3.52 billion, up 17% year-over-year (18% on a constant currency basis).1
- Net income attributable to Genpact Limited shareholders was $305 million, up 8% year-over-year, with a corresponding margin of 8.7%.
- Income from operations was $429 million, up 23% year-over-year, with a corresponding margin of 12.2%. Adjusted income from operations was $559 million, up 18% year-over-year, with a corresponding margin of 15.9%.3
- Diluted earnings per share was $1.56, up 8% year-over-year, and adjusted diluted earnings per share2 was $2.05, up 14% year-over-year.
- New bookings were approximately $3.9 billion, consistent with 2018.4
- Cash generated from operations was $428 million, compared to $340 million in 2018.
Key Financial Results – Fourth Quarter 2019
- Total revenue was $941 million, up 13% year-over-year both on an as reported and constant currency basis.1
- Net income attributable to Genpact Limited shareholders was $82 million, up 4% year-over-year, with a corresponding margin of 8.7%.
- Income from operations was $120 million, up 8% year-over-year, with a corresponding margin of 12.7%. Adjusted income from operations was $159 million, up 12% year-over-year, with a corresponding margin of 16.9%.3
- Diluted earnings per share was $0.42, up 2% year-over-year, and adjusted diluted earnings per share2 was $0.57, up 10% year-over-year.
Revenue Details – Full Year 2019
Total Company
- Total BPO revenue was $2.97 billion, up 19% year-over-year, representing 84% of total revenue.
- Total IT revenue was $546 million, up 10% year-over-year, representing 16% of total revenue.
Global Clients
- Revenue from Global Clients was $3.04 billion,5 up 11% year-over-year (12% on a constant currency basis),1 representing 86% of total revenue.
- Global Client BPO revenue was $2.64 billion, up 13% year-over-year (14% on a constant currency basis).1
- Global Client IT revenue was $400 million, up 3% year-over-year.
GE
- Revenue from GE was $478 million5, up 78% year-over-year, representing 14% of total revenue.
- GE BPO revenue was $332 million, up 110% year-over-year.
- GE IT revenue was $146 million, up 32% year-over-year.
Revenue Details – Fourth Quarter 2019
Total Company
- Total BPO revenue was $801 million, up 14% year-over-year, representing 85% of total revenue.
- Total IT revenue was $140 million, up 3% year-over-year, representing 15% of total revenue.
Global Clients
- Revenue from Global Clients was $811 million5, up 7% year-over-year (8% on a constant currency basis),1 representing 86% of total revenue.
- Global Client BPO revenue was $711 million, up 9% year-over-year (10% on a constant currency basis).1
- Global Client IT revenue was $100 million, down 4% year-over-year.
GE
- Revenue from GE was $129 million5, up 61% year-over-year, representing 14% of total revenue.
- GE BPO revenue was $90 million, up 81% year-over-year.
- GE IT revenue was $40 million, up 29% year-over-year.
2020 Outlook
Genpact expects:
- Total revenue for the full year of $3.89 to $3.95 billion, up 10.5% to 12.5% both on an as reported and constant currency basis.1
- Global Client revenue growth in the range of 12% to 14% both on an as reported and constant currency basis.1
- Adjusted income from operations margin6 of approximately 16.0%.
- Adjusted diluted EPS7 of $2.24 to $2.28.
Conference Call to Discuss Financial Results
Genpact's management will host an hour-long conference call beginning at 4:30 p.m. ET on February 6, 2020 to discuss the company's performance for the fourth quarter and full year ended December 31, 2019. To participate, callers can dial +1 (877) 654-0173 from within the U.S. or +1 (281) 973-6289 from any other country. Callers will be prompted to enter the conference ID, 7297984.
A live webcast of the call will also be made available on the Genpact Investor Relations website at https://www.genpact.com/investors. For those who cannot join the call live, a replay will be archived on the Genpact website after the end of the call. A transcript of the call will also be made available on the website.
About Genpact
Genpact G is a global professional services firm that makes business transformation real. We drive digital-led innovation and digitally-enabled intelligent operations for our clients, guided by our experience running thousands of processes primarily for Global Fortune 500 companies. We think with design, dream in digital, and solve problems with data and analytics. Combining our expertise in end-to-end operations and our AI-based platform, Genpact Cora, we focus on the details – all 90,000+ of us. From New York to New Delhi and more than 30 countries in between, we connect every dot, reimagine every process, and reinvent companies' ways of working. We know that reimagining each step from start to finish creates better business outcomes. Whatever it is, we'll be there with you – accelerating digital transformation to create bold, lasting results – because transformation happens here.
Safe Harbor
This press release contains certain statements concerning our future growth prospects and financial results and other forward-looking statements, as defined in the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements involve a number of risks, uncertainties and other factors that could cause actual results to differ materially from those in such forward-looking statements. These risks, uncertainties, and other factors include but are not limited to a slowdown in the economies and sectors in which our clients operate, a slowdown in the business process outsourcing or information technology services sectors, our ability to develop and successfully execute our business strategies, the risks and uncertainties arising from our past and future acquisitions, our ability to convert bookings to revenues, our ability to manage growth, factors which may impact our cost advantage, wage increases, changes in tax rates and tax legislation and other laws and regulations, our ability to attract and retain skilled professionals, risks and uncertainties regarding fluctuations in our earnings, foreign currency fluctuations, general economic conditions affecting our industry, political, economic or business conditions in countries in which we operate, including the uncertainty relating to the withdrawal of the United Kingdom from the European Union, commonly known as Brexit, as well as other risks detailed in our reports filed with the U.S. Securities and Exchange Commission, including Genpact's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. These filings are available at www.sec.gov. Genpact may from time to time make additional written and oral forward-looking statements, including statements contained in our filings with the Securities and Exchange Commission and our reports to shareholders. Although Genpact believes that these forward-looking statements are based on reasonable assumptions, you are cautioned not to put undue reliance on these forward-looking statements, which reflect management's current analysis of future events and should not be relied upon as representing management's expectations or beliefs as of any date subsequent to the time they are made. Genpact undertakes no obligation to update any forward-looking statements that may be made from time to time by or on behalf of Genpact.
Contacts
Investors | Roger Sachs, CFA | |
+1 (203) 808-6725 | ||
Media | Michael Schneider +1 (217) 260-5041
| |
GENPACT LIMITED AND ITS SUBSIDIARIES Consolidated Balance Sheets (Unaudited) (In thousands, except per share data and share count) | ||||||||
As of December 31, | As of December 31, | |||||||
2018 | 2019 | |||||||
Assets | ||||||||
Current assets | ||||||||
Cash and cash equivalents | $ | 368,396 | $ | 467,096 | ||||
Accounts receivable, net | 774,184 | 914,255 | ||||||
Prepaid expenses and other current assets | 212,477 | 170,325 | ||||||
Total current assets | $ | 1,355,057 | $ | 1,551,676 | ||||
Property, plant and equipment, net | 212,715 | 254,035 | ||||||
Operating lease right-of-use assets | — | 330,854 | ||||||
Deferred tax assets | 74,566 | 89,715 | ||||||
Investment in equity affiliates | 836 | — | ||||||
Intangible assets, net | 177,087 | 230,861 | ||||||
Goodwill | 1,393,832 | 1,574,466 | ||||||
Contract cost assets | 160,193 | 205,498 | ||||||
Other assets | 155,159 | 217,079 | ||||||
Total assets | $ | 3,529,445 | $ | 4,454,184 | ||||
Liabilities and equity | ||||||||
Current liabilities | ||||||||
Short-term borrowings | 295,000 | 70,000 | ||||||
Current portion of long-term debt | 33,483 | 33,509 | ||||||
Accounts payable | 42,584 | 21,981 | ||||||
Income taxes payable | 33,895 | 43,186 | ||||||
Accrued expenses and other current liabilities | 571,350 | 683,871 | ||||||
Operating leases liability | — | 57,664 | ||||||
Total current liabilities | $ | 976,312 | $ | 910,211 | ||||
Long-term debt, less current portion | 975,645 | 1,339,796 | ||||||
Operating leases liability | — | 302,100 | ||||||
Deferred tax liabilities | 8,080 | 3,990 | ||||||
Other liabilities | 165,226 | 208,916 | ||||||
Total liabilities | $ | 2,125,263 | $ | 2,765,013 | ||||
Shareholders' equity | ||||||||
Preferred shares, $0.01 par value, 250,000,000 authorized, none issued | — | — | ||||||
Common shares, $0.01 par value, 500,000,000 authorized, 189,346,101 and | 1,888 | 1,896 | ||||||
Additional paid-in capital | 1,471,301 | 1,570,575 | ||||||
Retained earnings | 438,453 | 648,656 | ||||||
Accumulated other comprehensive income (loss) | (507,460) | (531,956) | ||||||
Total equity | $ | 1,404,182 | $ | 1,689,171 | ||||
Total liabilities and equity | $ | 3,529,445 | $ | 4,454,184 | ||||
GENPACT LIMITED AND ITS SUBSIDIARIES Consolidated Statements of Income (Unaudited) (In thousands, except per share data and share count) | ||||||||||||
Three months ended December 31, | ||||||||||||
20178 | 2018 | 2019 | ||||||||||
Net revenues | $ | 734,413 | $ | 835,339 | $ | 940,739 | ||||||
Cost of revenue | 454,803 | 533,134 | 630,648 | |||||||||
Gross profit | $ | 279,610 | $ | 302,205 | $ | 310,091 | ||||||
Operating expenses: | ||||||||||||
Selling, general and administrative expenses | 188,817 | 178,580 | 212,650 | |||||||||
Amortization of acquired intangible assets | 10,632 | 9,716 | 9,047 | |||||||||
Other operating (income) expense, net | 6,856 | 3,068 | (31,124) | |||||||||
Income from operations | $ | 73,305 | $ | 110,841 | $ | 119,518 | ||||||
Foreign exchange gains (losses), net | (49) | 186 | 4,083 | |||||||||
Interest income (expense), net | (7,668) | (9,473) | (9,971) | |||||||||
Other income (expense), net | 15,971 | 5,078 | 719 | |||||||||
Income before equity-method investment activity, net and income tax expense | $ | 81,559 | $ | 106,632 | $ | 114,349 | ||||||
Equity-method investment activity, net | 24 | 10 | — | |||||||||
Income before income tax expense | $ | 81,583 | $ | 106,642 | $ | 114,349 | ||||||
Income tax expense | 15,445 | 27,495 | 32,151 | |||||||||
Net income | $ | 66,138 | $ | 79,147 | $ | 82,198 | ||||||
Net loss attributable to redeemable non-controlling interest | 944 | — | — | |||||||||
Net income attributable to Genpact Limited shareholders | $ | 67,082 | $ | 79,147 | $ | 82,198 | ||||||
Net income available to Genpact Limited common shareholders | $ | 67,082 | $ | 79,147 | $ | 82,198 | ||||||
Earnings per common share attributable to Genpact Limited | ||||||||||||
Basic | $ | 0.35 | $ | 0.42 | $ | 0.43 | ||||||
Diluted | $ | 0.34 | $ | 0.41 | $ | 0.42 | ||||||
Weighted average number of common shares used in computing | ||||||||||||
Basic | 192,795,534 | 189,724,744 | 190,083,647 | |||||||||
Diluted | 196,862,168 | 193,149,836 | 196,592,325 | |||||||||
GENPACT LIMITED AND ITS SUBSIDIARIES Consolidated Statements of Income (Unaudited) (In thousands, except per share data and share count) | ||||||||||||
Three months ended December 31, | ||||||||||||
20179 | 2018 | 2019 | ||||||||||
Net revenues | $ | 2,736,929 | $ | 3,000,790 | $ | 3,520,543 | ||||||
Cost of revenue | 1,681,438 | 1,921,768 | 2,294,688 | |||||||||
Gross profit | $ | 1,055,491 | $ | 1,079,022 | $ | 1,225,855 | ||||||
Operating expenses: | ||||||||||||
Selling, general and administrative expenses | 689,461 | 693,865 | 794,901 | |||||||||
Amortization of acquired intangible assets | 36,412 | 38,850 | 32,612 | |||||||||
Other operating (income) expense, net | (1,661) | (1,845) | (31,034) | |||||||||
Income from operations | $ | 331,279 | $ | 348,152 | $ | 429,376 | ||||||
Foreign exchange gains (losses), net | 1,996 | 15,239 | 7,729 | |||||||||
Interest income (expense), net | (31,735) | (37,119) | (43,458) | |||||||||
Other income (expense), net | 23,586 | 35,761 | 5,786 | |||||||||
Income before equity-method investment activity, net and income tax expense | $ | 325,126 | $ | 362,033 | $ | 399,433 | ||||||
Equity-method investment activity, net | (4,543) | (12) | (16) | |||||||||
Income before income tax expense | $ | 320,583 | $ | 362,021 | $ | 399,417 | ||||||
Income tax expense | 59,742 | 80,763 | 94,536 | |||||||||
Net income | $ | 260,841 | $ | 281,258 | $ | 304,881 | ||||||
Net loss attributable to redeemable non-controlling interest | 2,270 | 761 | — | |||||||||
Net income attributable to Genpact Limited shareholders | $ | 263,111 | $ | 282,019 | $ | 304,881 | ||||||
Net income available to Genpact Limited common shareholders | $ | 263,111 | $ | 282,019 | $ | 304,881 | ||||||
Earnings per common share attributable to Genpact Limited | ||||||||||||
Basic | $ | 1.36 | $ | 1.48 | $ | 1.60 | ||||||
Diluted | $ | 1.34 | $ | 1.45 | $ | 1.56 | ||||||
Weighted average number of common shares used in computing | ||||||||||||
Basic | 193,864,755 | 190,674,740 | 190,074,475 | |||||||||
Diluted | 197,049,552 | 193,980,038 | 195,160,855 | |||||||||
GENPACT LIMITED AND ITS SUBSIDIARIES Consolidated Statements of Cash Flows (Unaudited) (In thousands) | ||||||||||||
Year ended December 31, | ||||||||||||
2017 | 2018 | 2019 | ||||||||||
Operating activities | ||||||||||||
Net income attributable to Genpact Limited shareholders | $ | 263,111 | $ | 282,019 | $ | 304,881 | ||||||
Net (loss) attributable to redeemable non-controlling interest | (2,270) | (761) | — | |||||||||
Net income | $ | 260,841 | $ | 281,258 | $ | 304,881 | ||||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
Depreciation and amortization | 58,503 | 64,868 | 96,101 | |||||||||
Amortization of debt issuance costs (including loss on extinguishment of debt) | 1,884 | 3,975 | 1,779 | |||||||||
Amortization of acquired intangible assets | 36,412 | 38,850 | 32,612 | |||||||||
Write-down of intangible assets and property, plant and equipment | 9,311 | 4,265 | 3,511 | |||||||||
Reserve for doubtful receivables | 9,819 | 1,857 | 7,443 | |||||||||
Unrealized loss (gain) on revaluation of foreign currency asset/liability | (11,830) | 3,352 | (5,171) | |||||||||
Equity-method investment activity, net | 4,543 | 12 | 16 | |||||||||
Stock-based compensation expense | 35,685 | 48,998 | 83,885 | |||||||||
Deferred tax expense (benefit) | (10,391) | 6,054 | (16,315) | |||||||||
Loss (gain) on divestiture | 5,668 | — | — | |||||||||
Gain on exchange of non-monetary asset | (4,100) | — | (31,380) | |||||||||
Others, net | (685) | 1,317 | (2,229) | |||||||||
Change in operating assets and liabilities: | ||||||||||||
Increase in accounts receivable | (57,267) | (76,894) | (121,983) | |||||||||
Increase in prepaid expenses, other current assets, contract cost assets, | (28,381) | (76,392) | (69,813) | |||||||||
Increase (decrease) in accounts payable | (2,155) | 26,401 | (21,375) | |||||||||
Increase in accrued expenses, other current liabilities, operating lease | 46,581 | 5,993 | 157,580 | |||||||||
Increase (decrease) in income taxes payable | 4,640 | 5,597 | 8,346 | |||||||||
Net cash provided by operating activities | $ | 359,078 | $ | 339,511 | $ | 427,888 | ||||||
Investing activities | ||||||||||||
Purchase of property, plant and equipment | (57,231) | (84,978) | (74,927) | |||||||||
Payment for internally generated intangible assets (including intangibles | (16,441) | (75,439) | (33,834) | |||||||||
Proceeds from sale of property, plant and equipment | 1,738 | 668 | 1,750 | |||||||||
Investment in equity affiliates | (496) | — | — | |||||||||
Proceeds from sale of equity affiliates | — | — | 2,168 | |||||||||
Payment for business acquisitions, net of cash acquired | (284,822) | (111,571) | (252,276) | |||||||||
Proceeds from divestiture of business, net of cash divested | (4,738) | — | — | |||||||||
Payment for purchase of redeemable non-controlling interest | — | (4,730) | — | |||||||||
Net cash used for investing activities | $ | (361,990) | $ | (276,050) | $ | (357,119) | ||||||
Financing activities | ||||||||||||
Repayment of capital/finance lease obligations | (2,708) | (2,395) | (7,380) | |||||||||
Payment of debt issuance costs | (2,630) | (4,293) | (2,317) | |||||||||
Proceeds from long-term debt | 350,000 | 129,186 | 400,000 | |||||||||
Repayment of long-term debt | (40,000) | (166,186) | (34,000) | |||||||||
Proceeds from short-term borrowings | 295,000 | 250,000 | 400,000 | |||||||||
Repayment of short-term borrowings | (285,000) | (125,000) | (625,000) | |||||||||
Proceeds from issuance of common shares under stock-based | 15,528 | 14,034 | 19,670 | |||||||||
Payment for net settlement of stock-based awards | (10,296) | (15,919) | (3,850) | |||||||||
Payment of earn-out/deferred consideration | (6,219) | (3,356) | (12,790) | |||||||||
Dividend paid | (46,686) | (57,102) | (64,671) | |||||||||
Payment for stock repurchased and retired | (219,784) | (154,058) | (30,000) | |||||||||
Payment for expenses related to stock repurchase | (16) | (98) | (15) | |||||||||
Net cash provided by/(used for) financing activities | $ | 47,189 | $ | (135,187) | $ | 39,647 | ||||||
Effect of exchange rate changes | 37,568 | (64,346) | (11,716) | |||||||||
Net increase (decrease) in cash and cash equivalents | 44,277 | (71,726) | 110,416 | |||||||||
Cash and cash equivalents at the beginning of the period | 422,623 | 504,468 | 368,396 | |||||||||
Cash and cash equivalents at the end of the period | $ | 504,468 | $ | 368,396 | $ | 467,096 | ||||||
Supplementary information | ||||||||||||
Cash paid during the period for interest (including interest | $ | 27,915 | $ | 41,484 | $ | 45,084 | ||||||
Cash paid during the period for income taxes (net of refunds) | $ | 66,238 | $ | 81,411 | $ | 104,217 | ||||||
Property, plant and equipment acquired under capital/finance | $ | 2,318 | $ | 2,031 | $ | 5,008 | ||||||
Non-cash transaction: Gain on exchange of non-monetary asset | $ | (4,100) | $ | — | $ | (31,380) | ||||||
Non-GAAP Financial Measures
To supplement the consolidated financial statements presented in accordance with GAAP, this press release includes the following non-GAAP financial measures:
- Adjusted income from operations attributable to shareholders of Genpact Limited, or adjusted income from operations;
- Adjusted income from operations margin;
- Adjusted diluted earnings per share attributable to shareholders of Genpact Limited, or adjusted diluted earnings per share; and
- Revenue growth on a constant currency basis.
These non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles and should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and may be different from non-GAAP financial measures used by other companies. Accordingly, these non-GAAP financial measures, the financial statements prepared in accordance with GAAP and the reconciliations of Genpact's GAAP financial statements to such non-GAAP financial measures should be carefully evaluated.
Prior to July 2012, Genpact's management used financial statements that excluded significant acquisition-related expenses, amortization of related acquired intangibles, and amortization of acquired intangibles recorded at the company's formation in 2004 for its internal management reporting, budgeting and decision-making purposes, including comparing Genpact's operating results to that of its competitors. However, considering Genpact's frequent acquisitions of varying scale and size, and the difficulty in predicting expenses relating to acquisitions and the amortization of acquired intangibles thereof, since July 2012 Genpact's management has used financial statements that exclude all acquisition-related expenses and amortization of acquired intangibles for its internal management reporting, budgeting and decision-making purposes, including comparing Genpact's operating results to those of its competitors. For the same reasons, since April 2016 Genpact's management has excluded the impairment of acquired intangible assets from the financial statements it uses for internal management purposes. Acquisition-related expenses are excluded in the period in which an acquisition is consummated.
Genpact's management also uses financial statements that exclude stock-based compensation expense. Because of varying available valuation methodologies, subjective assumptions and the variety of award types that companies can use when adopting ASC 718 "Compensation-Stock Compensation," Genpact's management believes that providing non-GAAP financial measures that exclude such expenses allows investors to make additional comparisons between Genpact's operating results and those of other companies. Additionally, in its calculations of such non-GAAP financial measures, Genpact's management has adjusted foreign exchange gains and losses, interest income and expense and income tax expenses from GAAP net income attributable to Genpact Limited shareholders, and other income and expenses, certain gains, losses and impairment charges attributable to equity-method investments, and gains or losses attributable to non-controlling interests from GAAP income from operations because management believes that the Company's results after taking into account these adjustments more accurately reflect the Company's ongoing operations. For the purpose of calculating adjusted diluted earnings per share, the combined current and deferred tax effect is determined by multiplying each pre-tax adjustment by the applicable statutory income tax rate.
Genpact's management provides information about revenues on a constant currency basis so that revenues may be viewed without the impact of foreign currency exchange rate fluctuations compared to prior fiscal periods, thereby facilitating period-to-period comparisons of the Company's true business performance. Revenue growth on a constant currency basis is calculated by restating current-period activity using the prior fiscal period's foreign currency exchange rates adjusted for hedging gains/losses in such period.
Accordingly, Genpact believes that the presentation of adjusted income from operations, adjusted income from operations margin, adjusted diluted earnings per share and revenue growth on a constant currency basis, when read in conjunction with the Company's reported results, can provide useful supplemental information to investors and management regarding financial and business trends relating to its financial condition and results of operations.
A limitation of using adjusted income from operations and adjusted income from operations margin versus income from operations, income from operations margin, net income attributable to Genpact Limited shareholders and net income attributable to Genpact Limited shareholders margin calculated in accordance with GAAP is that these non-GAAP financial measures exclude certain recurring costs and certain other charges, namely stock-based compensation and amortization and impairment of acquired intangibles. Management compensates for this limitation by providing specific information on the GAAP amounts excluded from adjusted income from operations and adjusted income from operations margin.
The following tables show the reconciliation of these non-GAAP financial measures to the most directly comparable GAAP measures for the year and three months ended December 31, 2018 and 2019:
Reconciliation of Net income attributable to Genpact Limited shareholders/Margin to Adjusted Income (In thousands) | ||||||||||||||||
Year ended December 31, | Three months ended December 31, | |||||||||||||||
2018 | 2019 | 2018 | 2019 | |||||||||||||
Net income attributable to Genpact Limited shareholders | $ | 282,019 | $ | 304,881 | $ | 79,147 | $ | 82,198 | ||||||||
Less: Foreign exchange (gains) losses, net | (15,239) | (7,729) | (186) | (4,083) | ||||||||||||
Add: Interest (income) expense, net | 37,119 | 43,458 | 9,473 | 9,971 | ||||||||||||
Add: Income tax expense | 80,763 | 94,536 | 27,495 | 32,151 | ||||||||||||
Add: Stock-based compensation | 48,998 | 83,885 | 16,840 | 22,579 | ||||||||||||
Add: Amortization of acquired intangible assets | 37,292 | 31,458 | 9,333 | 8,768 | ||||||||||||
Add: Acquisition-related expenses | 2,362 | 8,352 | — | 7,385 | ||||||||||||
Adjusted income from operations | $ | 473,314 | $ | 558,841 | $ | 142,102 | $ | 158,969 | ||||||||
Net income attributable to Genpact Limited shareholders margin | 9.4 | % | 8.7 | % | 9.5 | % | 8.7 | % | ||||||||
Adjusted income from operations margin | 15.8 | % | 15.9 | % | 17.0 | % | 16.9 | % | ||||||||
Reconciliation of Income from Operations/Margin to Adjusted Income from Operations/Margin (In thousands) | ||||||||||||||||
Year ended December 31, | Three months ended December 31, | |||||||||||||||
2018 | 2019 | 2018 | 2019 | |||||||||||||
Income from operations | $ | 348,152 | $ | 429,376 | $ | 110,841 | $ | 119,518 | ||||||||
Add: Stock-based compensation | 48,998 | 83,885 | 16,840 | 22,579 | ||||||||||||
Add: Amortization of acquired intangible assets | 37,292 | 31,458 | 9,333 | 8,768 | ||||||||||||
Add: Acquisition-related expenses | 2,362 | 8,352 | — | 7,385 | ||||||||||||
Add: Other income (expense), net | 35,761 | 5,786 | 5,078 | 719 | ||||||||||||
Less: Equity-method investment activity, net | (12) | (16) | 10 | — | ||||||||||||
Add: Net loss attributable to redeemable non-controlling interest | 761 | — | — | — | ||||||||||||
Adjusted income from operations | $ | 473,314 | $ | 558,841 | $ | 142,102 | $ | 158,969 | ||||||||
Income from operations margin | 11.6 | % | 12.2 | % | 13.3 | % | 12.7 | % | ||||||||
Adjusted income from operations margin | 15.8 | % | 15.9 | % | 17.0 | % | 16.9 | % | ||||||||
Reconciliation of Diluted EPS to Adjusted Diluted EPS10 (Per share data) | ||||||||||||||||
Year ended December 31, | Three months ended December 31, | |||||||||||||||
2018 | 2019 | 2018 | 2019 | |||||||||||||
Diluted EPS | $ | 1.45 | $ | 1.56 | $ | 0.41 | $ | 0.42 | ||||||||
Add: Stock-based compensation | 0.25 | 0.43 | 0.09 | 0.11 | ||||||||||||
Add: Amortization of acquired intangible assets | 0.19 | 0.16 | 0.05 | 0.04 | ||||||||||||
Add: Acquisition-related expenses | 0.01 | 0.04 | — | 0.04 | ||||||||||||
Less: Tax impact on stock-based compensation | (0.06) | (0.10) | (0.02) | (0.02) | ||||||||||||
Less: Tax impact on amortization of acquired intangible assets | (0.05) | (0.04) | (0.01) | (0.01) | ||||||||||||
Less: Tax impact on acquisition-related expenses | — | (0.01) | — | (0.01) | ||||||||||||
Adjusted diluted EPS | $ | 1.80 | $ | 2.05 | $ | 0.52 | $ | 0.57 | ||||||||
The following tables show the reconciliation of forward-looking non-GAAP financial measures to the most directly comparable GAAP measures for the year ending December 31, 2020:
Reconciliation of Outlook for Net income attributable to Genpact Limited shareholders Margin to | ||||
Year ending December 31, 2020 | ||||
Net income attributable to Genpact Limited shareholders margin | 8.8 | % | ||
Add: Foreign exchange (gains) losses, net | — | |||
Add: Interest (income) expense, net | 1.1 | % | ||
Add: Income tax expense | 2.8 | % | ||
Add: Estimated stock-based compensation | 2.1 | % | ||
Add: Estimated amortization of acquired intangible assets | 1.1 | % | ||
Add: Estimated acquisition-related expenses | 0.1 | % | ||
Adjusted income from operations margin | 16.0 | % | ||
Reconciliation of Outlook for Income from Operations Margin to Adjusted Income from Operations | ||||
Year ending December 31, 2020 | ||||
Income from operations margin | 12.7 | % | ||
Add: Estimated stock-based compensation | 2.1 | % | ||
Add: Estimated amortization of acquired intangible assets | 1.1 | % | ||
Add: Estimated acquisition-related expenses | 0.1 | % | ||
Add: Estimated other income (expense), net | — | |||
Less: Estimated equity-method investment activity, net | — | |||
Adjusted income from operations margin | 16.0 | % | ||
Reconciliation of Outlook for Diluted EPS to Adjusted Diluted EPS11 (Per share data) | ||||||||
Year ending December 31, 2020 | ||||||||
Lower | Upper | |||||||
Diluted EPS | $ | 1.73 | $ | 1.77 | ||||
Add: Estimated stock-based compensation | 0.43 | 0.43 | ||||||
Add: Estimated amortization of acquired intangible assets | 0.22 | 0.22 | ||||||
Add: Estimated acquisition-related expenses | 0.02 | 0.02 | ||||||
Less: Estimated tax impact on stock-based compensation | (0.10) | (0.10) | ||||||
Less: Estimated tax impact on amortization of acquired intangibles | (0.06) | (0.06) | ||||||
Less: Estimated tax impact on acquisition-related expenses | — | — | ||||||
Adjusted diluted EPS | $ | 2.24 | $ | 2.28 | ||||
1 Revenue growth on a constant currency basis is a non-GAAP measure and is calculated by restating current-period activity using the prior fiscal period's foreign currency exchange rates adjusted for hedging gains/losses in such period.
2 Adjusted diluted earnings per share is a non-GAAP measure. A reconciliation of GAAP diluted earnings per share to adjusted diluted earnings per share is attached to this release.
3 Adjusted income from operations and adjusted income from operations margin are non-GAAP measures. Reconciliations of each of GAAP income from operations and GAAP net income attributable to Genpact Limited shareholders to adjusted income from operations and GAAP income from operations margin and GAAP net income attributable to Genpact Limited shareholders margin to adjusted income from operations margin are attached to this release.
4 New bookings, an operating measure, represents the total contract value of new contracts and certain renewals, extensions and changes to existing contracts. Regular renewals of contracts with no change in scope are not counted as new bookings.
5 During the year ended December 31, 2019, GE divested certain businesses that Genpact continues to serve. We have reclassified the revenue from such GE-divested businesses as Global Client revenue. If we had not reclassified such revenue, Global Client revenues for the full year 2019 and quarter ended December 31, 2019 would have been $3.03 billion and $808 million, respectively, and GE revenues would have been $489 million and $133 million, respectively.
6 Adjusted income from operations margin is a non-GAAP measure. A reconciliation of the outlook for each of GAAP income from operations margin and GAAP net income attributable to Genpact Limited shareholders margin to adjusted income from operations margin is attached to this release.
7 Adjusted diluted earnings per share is a non-GAAP measure. A reconciliation of the outlook for GAAP diluted earnings per share to adjusted diluted earnings per share is attached to this release.
8 Cost of revenue, selling, general and administrative expenses, other income (expense) and income from operations for the three months ended December 31, 2017 have been restated due to the adoption of ASU No. 2017-07 with effect from January 1, 2018. The impact of such restatement is not material.
9 Cost of revenue, selling, general and administrative expenses, other income (expense) and income from operations for the year ended December 31, 2017 have been restated due to the adoption of ASU No. 2017-07 with effect from January 1, 2018. The impact of such restatement is not material.
10 Due to rounding, the numbers presented in this table may not add up precisely to the totals provided.
11 Due to rounding, the numbers presented in this table may not add up precisely to the totals provided.
View original content to download multimedia:http://www.prnewswire.com/news-releases/genpact-reports-full-year-and-fourth-quarter-2019-results-301000637.html
SOURCE Genpact
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
